UBS Group »

60 Degrees Pharmaceuticals I shares owned by UBS Group

Quarter-by-quarter ownership of 60 Degrees Pharmaceuticals I shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in 60 Degrees Pharmaceuticals I

Tip: Access up to 7 years of quarterly data

All positions including 60 Degrees Pharmaceuticals I held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 60 Degrees Pharmaceuticals I by UBS Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $55k 31k 1.75

More positions owned by UBS Group

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Amazon (AMZN)
Meta Platforms Cl A (META)
Spdr Gold Tr Gold Shs (GLD)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Msci Eafe (IEFA)
Alphabet Cap Stk Cl C (GOOG)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Ubs Group SHS (UBS)

View all positions for UBS Group

Top funds holding 60 Degrees Pharmaceuticals I

Kathmere Capital Management
UBS Group
Geode Capital Management
Goss Wealth Management
Twin Peaks Wealth Advisors
Citigroup

View all funds holding 60 Degrees Pharmaceuticals I